Diseases & Conditions Market Research Reports & Industry Analysis
Insomnia is a common condition in which one has trouble going to sleep or staying asleep. This condition can range from weak to strong, depending on how often it occurs and for how long. Insomnia can be ongoing or acute. Chronic insomnia means having symptoms at least 3 nights a week for more than a month. Acute insomnia lasts for less time. Some people who have insomnia will have trouble falling asleep. Other people may fall asleep easily but, then wake up.
Diseases & Conditions Industry Research & Market Reports
-
Dairy Enzymes
... at a CAGR of 6.8% over the analysis period 2023-2030. Chymosin, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$442.0 Million by the end of the ... Read More
-
Antipsychotic Drugs
... at a CAGR of 6.7% over the analysis period 2023-2030. Second Generation Antipsychotic Drugs, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$15.7 Billion by the ... Read More
-
Dengue Testing
... at a CAGR of 4.9% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$367.8 Million by the end of ... Read More
-
Insomnia Drugs
... at a CAGR of 5.7% over the analysis period 2023-2030. Prescription Sleep Aids, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$4.5 Billion by the end ... Read More
-
Post-Traumatic Stress Disorder (PTSD) Therapeutics
... is expected to reach US$4.0 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Antidepressants, one of the segments analyzed in the report, is expected to record a 4.9% CAGR ... Read More
-
Dengue Vaccine
... at a CAGR of 15.8% over the analysis period 2023-2030. Government Institutions End-Use, one of the segments analyzed in the report, is expected to record a 14.2% CAGR and reach US$774.6 Million by the end ... Read More
-
Infectious Disease Diagnostics
... by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Assays & Reagents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$25.8 Billion ... Read More
-
Herpes Zoster Treatment
... by 2030, growing at a CAGR of 1.9% over the analysis period 2023-2030. Antiviral Medications, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$134.0 Million by ... Read More
-
Non-muscle Invasive Bladder Cancer (NMIBC) - Epidemiology Forecast - 2034
... stage Ta, followed by T1 and Tis in the United States, while PUN-LMP accounted for the least prevalent stage, with ~6,800 cases in 2023 NMIBC is an age-associated malignancy, with a median age at diagnosis ... Read More
-
Europe Breast Cancer Screening Market Forecast Report by Europe Breast Cancer Screening Market (Mammography Screening Market, MRI Screening Market, Ultrasound Screening Market) Countries (United Kingdom, France, Germany, Italy, Spain, Switzerland, Norway, Netherlands) and Company Analysis, 2024-2032
... 2024-2032 Transportation Battery Market Analysis Global Transportation Battery Market was US$ 85.67 Billion in 2023 and will grow US$ 263.78 Billion by 2032, with a CAGR of 13.31% from 2024 to 2032. The primary factors ... Read More
-
OLED Panel Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global OLED panel market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global OLED ... Read More
-
Global Digital Brain Health Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2032
... Region, and Segment Forecasts, 2023 – 2032 Global Digital Brain Health market was valued at US $198.1 Billion in 2022 and is expected to reach ~US $400 Billion by 2032, growing at a CAGR of ... Read More
-
Chronic Disease Management Market, By Disease Type (Cardiovascular Diseases, Diabetes, Respiratory Diseases, Cancer, Chronic Kidney Disease, and Others (Arthritis, etc.)), By Service Type (Disease Management Programs, Remote Patient Monitoring, Telehealth Services, and Others (Diagnostic Services, etc.)), By Delivery Mode (On-premise, Web-based, and Cloud-based), By End User (Hospitals, Specialty Clinics, Home Care Settings, and Others (Pharmaceutical Companies, etc.)), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... etc.)), By Delivery Mode (On-premise, Web-based, and Cloud-based), By End User (Hospitals, Specialty Clinics, Home Care Settings, and Others (Pharmaceutical Companies, etc.)), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) ... Read More
-
Global Dengue Vaccine Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2030
... Segment Forecasts, 2023 – 2030 The Global Dengue Vaccine Market was valued around US $390.55 million in 2022 and is expected to reach US $1292.20 million by 2030 with a CAGR of 16.13% during the ... Read More
-
Opioid Overdose - Pipeline Insight, 2024
... clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage ... Read More
-
Anti-Snoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
... (Hospital and Retail Pharmacies, Online Pharmacies, and Others), Usability (Reusable and Disposable), Application (Vaccine, Insulin, Dermatology, and Others), End-User (Hospitals, Clinics, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the ... Read More
-
Crowd Analytics
... at a CAGR of 20.6% over the analysis period 2023-2030. Crowd Analytics Solutions, one of the segments analyzed in the report, is expected to record a 18.6% CAGR and reach US$3.2 Billion by the end ... Read More
-
Diabetic Food
... at a CAGR of 4.7% over the analysis period 2023-2030. Dietary Beverages, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$6.2 Billion by the end of ... Read More
-
Intrathecal Pumps
... at a CAGR of 5.0% over the analysis period 2023-2030. Morphine, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$115.9 Million by the end of the ... Read More
-
Adult Vaccine Market Global Forecast Report by Disease wise (Influenza, Cervical Cancer (HPV), Zoster (Shingles), MMR (Measles, Mumps, and Rubella Vaccine), Pneumococcal, Meningococcal, Hepatitis, Tdap, Travel and Miscellaneous, Varicella) Countries and Company Analysis, 2024-2032
... Vaccine Market Analysis The global adult vaccine market was valued at US$ 20. 59 billion in 2023 and is projected to reach US$ 35.87 billion by 2032 with the compound annual growth rate of 6.36% ... Read More
-
Cervical Cancer Endoscopic Devices
... reach US$1.2 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. Optical Colposcopes, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach ... Read More
-
Diabetes Drugs
... at a CAGR of 9.3% over the analysis period 2023-2030. Insulin, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$123.1 Billion by the end of the ... Read More
-
Viral Hepatitis and Retrovirus Diagnostic Tests
... the year 2023, is expected to reach US$7.7 Billion by 2030, growing at a CAGR of 8.4% over the period 2023-2030. The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow ... Read More
-
Global Sleep Disorder Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2032
... Segment Forecasts, 2023 – 2032 Global Sleep Disorder market was valued US $22.5 Billion in 2022 and expected to reach US $70.8 Billion by 2032, growing at a CAGR of 12% during the forecast period ... Read More
-
Automotive Catalytic Converter
... by 2030, growing at a CAGR of 6.3% over the analysis period 2023-2030. Three-Way Oxidation Reduction Catalytic Converter, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach ... Read More